Enclomiphene vs hCG: which preserves fertility better on TRT

Last updated 2026-07-27

What is the actual difference between enclomiphene and hCG?

Enclomiphene blocks estrogen receptors in the hypothalamus. Your brain reads that as "estrogen is low," so it dumps out more GnRH, which pushes the pituitary to release more LH and FSH. Those two hormones then drive the testicles to make more testosterone and keep sperm production running. It's a top-down signal. Nothing external gets injected into the testicle; you're just turning up your own volume knob ^[1]. hCG (human chorionic gonadotropin) works at the bottom of that same chain. It's a glycoprotein hormone that binds the LH receptor directly on Leydig cells in the testicle, basically standing in for LH itself. That's why hCG is FDA-approved for hypogonadism treatment tied to pituitary problems, and for cryptorchidism and fertility induction in men with hypogonadotropic hypogonadism ^[2]. It doesn't touch the hypothalamus or pituitary at all. So one drug tells your brain to talk to your testicles louder. The other one talks to your testicles directly, skipping the brain conversation entirely. That distinction matters more than it sounds like, because it changes who each drug actually helps. One more thing worth being precise about: enclomiphene is not identical to clomiphene citrate (Clomid), even though the two are related. Clomiphene is a mixture of two isomers, enclomiphene and zuclomiphene. Enclomiphene is the isomer that does most of the estrogen-blocking, anti-estrogen work at the hypothalamus; zuclomiphene lingers in the body much longer (its half-life has been estimated at roughly 30 days versus about a day or two for enclomiphene) and is thought to contribute more of the estrogenic side effects some men get on clomiphene ^[3].

Is enclomiphene FDA-approved, and is hCG?

hCG is FDA-approved, but not for the exact off-label use most TRT patients want it for. Approved hCG products (brand names include Pregnyl and Novarel) are indicated for prepubertal cryptorchidism, hypogonadotropic hypogonadism, and as an adjunct for inducing ovulation in women; using it to prevent testicular shrinkage alongside injectable testosterone is common clinical practice but is technically off-label ^[2]. Enclomiphene has never been FDA-approved as a standalone drug. A company called Repros Therapeutics developed it under the name Androxal and ran it through Phase 3 trials in the 2010s, but the FDA did not approve it, and the program was eventually shelved ^[4]. What men buy today as "enclomiphene" is a compounded medication, made by a compounding pharmacy under a prescription, not a drug that went through the FDA's standard approval pathway for safety and efficacy in a specific indication. That's an important distinction to sit with before you buy anything. Compounded doesn't mean unregulated. Pharmacies that compound enclomiphene operate under state pharmacy boards and, for larger-scale operations, FDA oversight of compounding facilities under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act ^[5]. But it does mean you're not getting the same batch-to-batch, FDA-reviewed guarantee you'd get from a commercially approved tablet. If you want the details on how that sourcing model actually works, see Enclomiphene Direct compounding pharmacy vs research supplier.

Does enclomiphene preserve fertility better than TRT plus hCG?

Neither option has been proven in a large, controlled trial to guarantee fertility preservation or restoration; both have real, but limited, human data behind them. Here's what actually exists. For enclomiphene, the human evidence is a mix of small trials and case series. A 2019 open-label study in Translational Andrology and Urology followed hypogonadal men on enclomiphene citrate and found it raised testosterone into the normal range while maintaining LH, FSH, and sperm parameters better than what's typically seen with exogenous testosterone, though the study was small and not placebo-controlled the way a large registration trial would be ^[6]. The Androxal Phase 3 program itself reported testosterone normalization comparable to topical testosterone gel, with LH and FSH staying in range rather than getting suppressed, but that data was never enough to earn FDA approval, for reasons the company and FDA never fully disclosed publicly ^[4]. If you want the specific studies broken down, read Enclomiphene Direct human studies. For hCG combined with TRT, the data is older but more clinically established. A frequently cited 2005 study in the Journal of Urology found that low-dose hCG (250 IU every other day) added to testosterone therapy maintained intratesticular testosterone and testicular volume in men who would otherwise have suppressed both on TRT alone ^[7]. That's a mechanistic and volume-based outcome, not a live-birth or sperm-count-restoration guarantee, but it's a real, replicated clinical pattern that urologists rely on. What neither drug has: a large randomized trial proving it restores fertility in men who were already infertile, or proving pregnancy rates in partners. If a clinic promises that either option "preserves your fertility," ask them to define what they mean, because the honest answer is "it tends to keep the machinery running better than testosterone alone," not "it guarantees you'll conceive."

Enclomiphene vs hCG: head-to-head comparison

Can you take enclomiphene and hCG together?

Yes, in the sense that nothing about their mechanisms directly conflicts, but it's not a common combination and there isn't dedicated trial data on stacking them. Enclomiphene works by pushing your pituitary to make more LH and FSH; hCG works by acting like LH at the testicle regardless of what your pituitary is doing. Combining them doesn't create an obvious pharmacological problem, but there's no real reason to layer them if enclomiphene alone is already normalizing your testosterone and LH/FSH. Where this combination shows up more often, honestly, is in fertility clinics treating men with hypogonadotropic hypogonadism, where hCG (sometimes with FSH/human menopausal gonadotropin) is the primary fertility induction tool, and clomiphene-class drugs are sometimes used adjunctively. That's a different clinical picture than the average guy on TRT considering his options. If you're on injectable testosterone and want to protect fertility, hCG is the standard add-on. If you haven't started testosterone yet and want to avoid exogenous hormones altogether, enclomiphene as monotherapy is the more common path. Doing both at once is something to discuss with a prescriber who actually reviews your labs, not something to self-direct.

What are the side effects of enclomiphene vs hCG?

Enclomiphene's most commonly reported issues in trial data include headache, mood changes, and, rarely, visual disturbances, a class effect shared with clomiphene given the shared SERM mechanism ^[4][6]. Because it's a SERM working at the estrogen receptor, some men notice mood or libido shifts that track with how their body handles the estrogen-signaling change, not with a testosterone drop. hCG's side effect profile leans toward what you'd expect from raising testosterone (and, indirectly, estradiol) via a different route: injection site irritation, water retention, gynecomastia or nipple tenderness in men who aromatize a lot of the added testosterone, and mood swings tied to hormone fluctuation. Because hCG can raise estradiol as a downstream effect of higher testosterone production, some clinics pair it with an aromatase inhibitor, which introduces its own side effect profile and monitoring needs. Check Enclomiphene Direct drug interactions before combining anything with a SERM or a gonadotropin, since interaction risk depends heavily on what else is in your regimen. Neither drug carries the same cardiovascular and hematocrit-monitoring concerns that come with exogenous testosterone (like polycythemia risk), largely because both are working through the body's own production pathway rather than adding a supraphysiologic external dose directly.

How much does enclomiphene cost compared to hCG?

Pricing varies a lot by pharmacy, dose, and whether insurance covers any part of it (it usually doesn't, since both are largely off-label or non-approved uses). As a rough real-world range: compounded enclomiphene commonly runs somewhere in the neighborhood of $60 to $150 per month depending on dose and pharmacy, paid cash. hCG pricing depends on vial size and injection frequency, but monthly cash costs in TRT clinics commonly land in a similar broad range, sometimes higher if dosed at higher frequency or combined with an aromatase inhibitor. Neither of these numbers is something you should treat as gospel; pharmacy pricing shifts constantly and isn't standardized the way an FDA-approved generic's price is. Get an actual quote from whatever pharmacy is filling your specific prescription before budgeting around either option.

Which one is right for a man trying to preserve fertility on TRT?

If you haven't started testosterone therapy yet, and your labs show low testosterone with a functioning hypothalamic-pituitary-testicular axis, enclomiphene alone is worth discussing with a prescriber as a way to raise testosterone without introducing exogenous hormone at all. You keep your own LH and FSH signaling running, which is the reason testicular size and sperm production tend to hold up better than on plain injectable TRT. If you're already on injectable testosterone and don't want to stop it (maybe you've tried enclomiphene, maybe your levels needed more than a SERM could give you, maybe you just prefer injections), hCG is the standard fertility-preserving add-on your prescriber will likely reach for. It doesn't replace TRT, it protects the testicular function that TRT alone tends to shut down. What neither option is: a guaranteed fertility fix if you're already dealing with a fertility problem unrelated to testosterone suppression (varicocele, obstructive issues, genetic factors). If pregnancy is the actual goal, more than "not shutting down my testicles," a reproductive urologist and a semen analysis should come before either drug decision. It's also worth reading up on how animal-model data differs from what's shown in humans before assuming either drug's mechanism translates one-to-one; see Enclomiphene Direct animal studies vs human evidence for that context.

How do you dose and store each one?

Enclomiphene is typically dosed as a daily oral tablet, commonly in the 12.5mg to 25mg range in published trial data, though your actual prescription depends on your labs and your prescriber's judgment ^[6]. It's a compounded product, so storage guidance can vary by pharmacy; some formulations are shelf-stable at room temperature, others carry different handling instructions. If you're wondering whether your specific prescription needs a fridge, check does Enclomiphene Direct need to be refrigerated rather than guessing. hCG comes as a powder that needs reconstitution with bacteriostatic water before injection, and once mixed, it typically needs refrigeration and has a limited use window (commonly cited as 30 to 60 days once reconstituted, though check your specific product's insert). Dosing in the TRT-adjunct literature commonly cites regimens like 250 IU every other day to 500 IU two to three times weekly, but this is prescriber-directed and varies by goal (maintenance versus fertility induction) ^[7]. Neither of these is a start-and-forget medication. Both need periodic labs, both need a prescriber actually watching what your testosterone, LH, FSH, and estradiol are doing over time, and it's specifically providers who review those labs before adjusting dose that keep either option safe.

Where does this leave the decision in practice?

If you're weighing enclomiphene against hCG, you're really asking two different questions depending on where you are. "Should I try a pill that works through my own brain signaling instead of starting testosterone injections?" points toward enclomiphene. "I'm already injecting testosterone and want my testicles to keep working," points toward hCG. The honest caveat that applies to both: this is a real, active area of andrology research, not a solved problem. Enclomiphene direct routes typically connect you with a licensed prescriber who reviews labs and a compounding pharmacy partner who fills the prescription; that provider-reviewed structure exists specifically because dosing this correctly needs someone watching your numbers, not a fixed script. Don't let anyone sell you either option as a guarantee. Both are tools that work with your body's own hormone signaling, not replacements for a real workup if fertility is the actual clinical goal.

Frequently asked questions

Does enclomiphene lower sperm count like testosterone does?

Available evidence suggests enclomiphene tends to maintain or support LH, FSH, and sperm parameters better than exogenous testosterone, because it works by raising your own pituitary signaling rather than suppressing it ^[6]. But this comes from small trials, not a large fertility-outcomes study, so it's a reasonable expectation based on mechanism, not a guarantee.

Is hCG the same as testosterone?

No. hCG is a separate hormone that mimics LH at the testicle, prompting your own Leydig cells to produce testosterone and support sperm production. Testosterone therapy delivers the hormone directly. That's why hCG is typically added alongside TRT, not used as a replacement for it, when the goal is preserving testicular function ^[2][7].

Can enclomiphene replace TRT entirely?

For some men with intact hypothalamic-pituitary-testicular signaling, enclomiphene can raise testosterone into a normal range without exogenous testosterone, based on Phase 3 Androxal data and smaller published trials ^[4][6]. It won't work the same way for men with primary testicular failure, since it relies on the testicles being able to respond to more LH and FSH.

Why isn't enclomiphene FDA-approved if the trial data looked decent?

Repros Therapeutics ran enclomiphene through Phase 3 trials as Androxal, but the FDA did not grant approval, and the program was ultimately discontinued ^[4]. The company and FDA never made every reason public, so it's compounded off-label today rather than sold as an approved branded drug.

Is compounded enclomiphene safe if it's not FDA-approved?

Compounding pharmacies operate under state pharmacy board oversight and, for larger facilities, FDA rules under sections 503A/503B of the FD&C Act ^[5]. That's real regulation, but it's not the same as FDA review of a specific approved drug product, so sourcing from a legitimate, provider-reviewed pharmacy matters more than it would for an approved generic.

How long does it take for hCG to restore testicular size after TRT shutdown?

Clinical data on hCG's role is mostly about prevention, keeping testicular volume from shrinking while on TRT, rather than restoration timelines after shutdown already occurred. The 2005 Journal of Urology study measured maintained intratesticular testosterone and volume with concurrent low-dose hCG (250 IU every other day), not recovery after suppression ^[7].

What's the difference between clomiphene and enclomiphene?

Clomiphene citrate is a mixture of two isomers, enclomiphene and zuclomiphene. Enclomiphene does most of the anti-estrogen signaling at the hypothalamus and clears the body in roughly a day or two, while zuclomiphene lingers far longer, with estimates around 30 days, and is thought to drive more of clomiphene's estrogenic side effects ^[3].

Do you need to inject enclomiphene like hCG?

No. Enclomiphene is taken as an oral tablet, while hCG requires subcutaneous or intramuscular injection after reconstituting a powder with bacteriostatic water. That route difference is one of the more practical, day-to-day reasons men prefer one over the other.

Can enclomiphene and hCG be used together?

There's no strong mechanistic conflict, since one raises pituitary LH/FSH signaling and the other mimics LH directly at the testicle, but there isn't dedicated trial data on the combination in typical TRT patients. This pairing shows up more in fertility clinic settings for men with hypogonadotropic hypogonadism than in routine TRT management.

Does insurance cover enclomiphene or hCG?

Usually not, since both are commonly used off-label or, for enclomiphene, as a compounded non-approved product, for the fertility-preservation and TRT-alternative indications most men want. Expect cash pay in most cases; costs vary by pharmacy and dose, so get a specific quote rather than assuming a fixed price.

Which causes more side effects, enclomiphene or hCG?

They cause different side effects rather than one being clearly worse. Enclomiphene's reported issues include headache, mood changes, and rare visual disturbances tied to its SERM mechanism ^[4][6]. hCG's issues lean toward injection site reactions, water retention, and gynecomastia, often tied to the estradiol rise that follows higher testosterone output ^[2].

Is enclomiphene better than hCG for a man who wants kids soon?

Neither is a proven fertility guarantee. If you're not yet on testosterone and want to avoid it, enclomiphene monotherapy is the more common route. If you're already on injectable TRT, hCG is the standard add-on to protect testicular function. A semen analysis and a reproductive urologist's input matter more than the drug choice alone if conception timing is the priority.

Sources

1. Endocrine Society, Clinical Practice Guideline: Testosterone Therapy in Men with Hypogonadism: Mechanism of hypothalamic-pituitary-gonadal axis regulation and role of LH/FSH in testicular function
2. FDA, Novarel (chorionic gonadotropin for injection) prescribing information, NDA 017546: hCG's FDA-approved indications include hypogonadotropic hypogonadism, cryptorchidism, and fertility induction
3. Kim et al., 'Enclomiphene citrate for the treatment of secondary hypogonadism,' Expert Opinion on Pharmacotherapy, PMID 26758482: Enclomiphene and zuclomiphene are the two isomers of clomiphene citrate with differing half-lives and receptor activity
4. FDA, Androxal (enclomiphene citrate) New Drug Application review documents, NDA 022613: Enclomiphene was developed as Androxal and went through FDA review without gaining approval
5. 21 U.S.C. 353a and 353b, Federal Food, Drug, and Cosmetic Act, Sections 503A and 503B (pharmacy and outsourcing facility compounding): Compounding pharmacies operate under FDA oversight rules distinct from standard drug approval
6. Wiehle et al., 'Enclomiphene citrate for the treatment of secondary hypogonadism,' Translational Andrology and Urology, PMID 31380231: Enclomiphene raised testosterone while maintaining LH, FSH, and sperm parameters in hypogonadal men
7. Hsieh et al., 'Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy,' Journal of Urology, PMID 16093995: Low-dose hCG (250 IU every other day) maintained intratesticular testosterone and testicular volume during TRT